S
Stemnovate develops multi-organ modeling platforms for drug discovery, utilizing in vitro cell culture and digital karyotyping to assess drug metabolism and toxicity. The company addresses the need for safer clinical trials and improved patient outcomes, particularly for rare diseases in children.
Updated 20 months ago
Funding
$1.2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
IU
Funding rounds are not available yet.
Founders
Product
Features
- Stemnovate develops multi-organ modeling platforms for drug discovery, utilizing in vitro cell culture and digital karyotyping to assess drug metabolism and toxicity. The company addresses the need for safer clinical trials and improved patient outcomes, particularly for rare diseases in children.